NSI-532-IGF

N/A

Report date: 2024/11/29 11:23:39

Base Information

Drug NameNSI-532-IGF
Drug Alias NameHK-532-IGF1NSI-532.IGFNSI-532.IGF1
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionInsulin-like growth factor I modulatorsVascular endothelial growth factor A replacement
TargetsInsulin-like growth factor IVascular endothelial growth factor A
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNeuralstem Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPalisades Pharmaceuticals IncUniversity Of Michigan
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A